← All organizations
Highest phase reached
Phase 3
Timeline
2000s
- Jul 1, 2008
TherapeuticsMD— Founded
2010s
- Aug 10, 2018
ethinyl estradiol— Marketing Organization
- Aug 10, 2018
segesterone— NDA Secondary Org
Drugs by trial phase (6 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Marketed drugs (4)
Recent trials (10)
- NCT04290390Lead sponsorPhase 1Feb 12, 2020
- NCT04290390Study chairPhase 1Feb 12, 2020
- NCT04272008Study chairPhase 1Feb 11, 2020
- NCT04272008Lead sponsorPhase 1Feb 11, 2020
- NCT02224313CollaboratorN/ADec 1, 2015
- NCT02253173Lead sponsorPhase 3Sep 1, 2014
- NCT02019589Lead sponsorPhase 3Dec 1, 2013
- NCT01942668Lead sponsorPhase 3Sep 1, 2013
- NCT02449902Study directorPhase 2Jul 1, 2013
- NCT02449902Lead sponsorPhase 2Jul 1, 2013
Details
- Founded
- Boca Raton, FL, US Jul 1, 2008
- Last known activity
- Feb 12, 2020